| Schedule of Fair Value Measurement Methods |
The approaches, in order of strongest fair value evidence, are detailed as follows: | | | | | The market backsolve approach benchmarks the original issue price (OIP) of the company’s latest funding transaction as current value. | | Under a PWERM, the company value is based upon the probability-weighted present value of expected future investment returns, considering each of the possible future outcomes available to the enterprise. Possible future outcomes can include IPO scenarios, potential SPAC transactions, merger and acquisition transactions as well as other similar exit transactions of the investee. | | The income approach is used to estimate fair value based on the income streams, such as cash flows or earnings, that an asset or business can be expected to generate. |
The methods are detailed as follows: | | | | | The OPM model treats preferred stock as call options on the enterprise’s equity value, with exercise prices based on the liquidation preferences of the preferred stock. | | Under a PWERM, share value is based upon the probability-weighted present value of expected future investment returns, considering each of the possible future outcomes available to the enterprise, as well as the rights of each share class. | | The hybrid method is a combination of the PWERM and OPM. Under the hybrid method, multiple liquidity scenarios are weighted based on the probability of the scenario's occurrence, similar to the PWERM, while also utilizing the OPM to estimate the allocation of value in one or more of the scenarios. |
The Group measures fair value using the following fair value hierarchy that reflects the significance of the inputs used in making the measurements: | | Fair Value Hierarchy Level | | | Inputs that are quoted market prices (unadjusted) in active markets for identical instruments. | | Inputs other than quoted prices included within Level 1 that are observable either directly (i.e. as prices) or indirectly (i.e. derived from prices). | | Inputs that are unobservable. This category includes all instruments for which the valuation technique includes inputs not based on observable data and the unobservable inputs have a significant effect on the instruments' valuation. |
|
| Schedule of Changes in Assets, Level 3 Fair Value, Investments Held at Fair Value |
The following table summarizes the changes in all the Group’s investments held at fair value categorized as Level 3 in the fair value hierarchy: | | | | Level 3 Investments held at fair value | | Equity method loss recorded against LTI $ | | Balance as of January 1, 2024 | | | | Deconsolidation of Seaport - new investment in Seaport preferred shares | | | | Gain/(loss) on changes in fair value | | | | Equity method loss recorded against LTI | | | | Balance as of December 31, 2024 | | | | Investment in Vedanta preferred shares | | | | Conversion of Vedanta note to preferred shares | | | | Gain/(loss) on changes in fair value | | | | Equity method loss recorded against LTI, net | | | | Balance as of December 31, 2025 | | | |
|
| Schedule of Sensitivity Analysis of Fair Value Measurement to Changes in Unobservable Inputs, Liabilities |
The significant unobservable inputs used at December 31, 2025 in the fair value measurement of this investment and the sensitivity of the fair value measurement to changes in these significant unobservable inputs are summarized in the table below. | | | | | Investment Measured through Market Backsolve & PWERM | | | | Fair Value Increase/ (Decrease) $ | | | | | | | | | Probability of entering into an initial public offering ("IPO")* | | | | | | | |
*Assumed the IPO event occurs on June 30, 2026.
|
| Schedule of Fair Value Measurement and Classification |
The fair value of financial instruments by category as of December 31, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investment in notes from associates | | | | | | | | Investments held at fair value3 | | | | | | | | | | | | | | | | | | | | | | | | Subsidiary preferred shares | | | | | | | | Share-based liability awards | | | | | | | | Total financial liabilities | | | | | | | |
1.Excluded from the table above are short-term investments of $24,829 and cash equivalent of $124,538 that are classified at amortized cost as of December 31, 2025. The cost of these short-term investments and cash equivalent approximates current fair value. 2.Included within cash and cash equivalents. 3.The carrying amount of $217,419 reflects the fair value of $236,557 as of December 31, 2025, net of $19,138 in equity method loss allocated to the long-term interest. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investment in notes from associates | | | | | | | | Investments held at fair value3 | | | | | | | | | | | | | | | | | | | | | | | | Subsidiary preferred shares | | | | | | | | Share-based liability awards | | | | | | | | Total financial liabilities | | | | | | | |
1.Excluded from the table above are short-term investments of $86,666 and cash equivalent of $62,179 that are classified at amortized cost as of December 31, 2024. The cost of these short-term investments and cash equivalent approximates current fair value. 2.Included within cash and cash equivalents. 3.The carrying amount of $188,452 reflects the fair value of $193,758 as of December 31, 2024, net of $5,307 in equity method loss allocated to the long-term interest.
|